University of Minnesota Children’s Hospital, Fairview provides a full range of expert care for lung, airway and chest diseases of children including asthma, cystic fibrosis, chronic cough and breathing problems associated with congenital abnormalities of the airways and lung, with bronchopulmonary dysplasia, with neurologic and muscular diseases, with immunodeficiency, with cancer and with infections.
For cystic fibrosis, our experts provide care that sets the benchmark used by other programs throughout the country. Our programs are made possible by our research that provides the knowledge needed to advance care for these diseases. When appropriate, we offer opportunities to participate in clinical trials of new therapies.
We offer this care in ways that support our patients and their families. We provide a pulmonary nurse consultation line and a pediatric pulmonologist is always on call. Our nurses assist in coordinating complex care among us and other consultants.
Conditions We Treat
We care for all airway and lung conditions, including:
Diagnostic Tests of Neutrophil Oxidative Function and Chemotaxis -Chronic Granulomatous Disease Diagnostic Tests
Blood Tests, including Immune Function Analysis
Full Range of Microbiology Analysis
Education and Advice for Patients and Families
Comprehensive Treatment Plans -Chronic Lung Disease Management -Environmental Control Recommendations -Medication and Monitoring --Development of Individual Action Plan (For example, how to use medication depending on the stage of asthma a child is in)
Transition Plans for Teens
Adult Care
Surgery, Including Transplants
Genetic Counseling
Current Research
Studies on the following topics are currently underway:
How Immune Responses in Asthma and Cystic Fibrosis Change Airways (Scarring, Remodeling)
How Toxins Produced by Staphylococcal Infections May Change Airway Barrier Function (Make Airways More Permeable)
Cystic Fibrosis Gene and New Therapy Development (in collaboration with a national network of 18 CF Centers, funded by the Cystic Fibrosis Foundation)
High Frequency Chest Compression Treatment with Machines, including Model 101, Model 102, Model 103, Model 104, and the inCourage System
Improving the Gibson Cooke Sweat Test for the Diagnosis of CF
Development of a New Pulmonary Function Test for Infants
Among First in State to Offer CLIA-Approved Diagnostic Tests of Neutrophil Oxidative Function and Chemotaxis
Department Highlights
Only Comprehensive Cystic Fibrosis Treatment Center in Minnesota Certified by the Cystic Fibrosis Foundation
Only Pediatric Lung Transplant Center in Minnesota
CLIA-Approved Pediatric Pulmonary Function Laboratory and Pulmonary Host Defense Laboratory
Helped Implement Minnesota’s Cystic Fibrosis Screening Program
Developed All Basic Technology for High Frequency Chest Compression and All Three Waveforms That Have Been Used Clinically
Developed the Quantum Patch Sweat Test for Cystic Fibrosis
Developed the National Cystic Fibrosis Database
Organized the International Study of Aging in Patients with Cystic Fibrosis
Developed the First Computerized Pulmonary Function Laboratory in Minnesota
University of Minnesota Children's Hospital 
Services 
Clinical Specialties 
